Holen Sie sich die Stockscreener-App
51.43
0.77%
-0.40
Handel nachbörslich:
51.54
0.11
+0.21%
Schlusskurs vom Vortag:
$51.83
Offen:
$51.71
24-Stunden-Volumen:
18.15M
Relative Volume:
0.88
Marktkapitalisierung:
$74.53B
Einnahmen:
$20.62B
Nettoeinkommen (Verlust:
$3.56B
KGV:
21.57
EPS:
2.3847
Netto-Cashflow:
$3.48B
1W Leistung:
+1.92%
1M Leistung:
+16.81%
6M Leistung:
-32.59%
1J Leistung:
-50.15%
1-Tages-Spanne:
$51.24
$52.06
1-Wochen-Bereich:
$50.02
$52.99
52-Wochen-Spanne:
$42.20
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
51.43 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
110.37 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.68 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.60 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
EW
Edwards Lifesciences Corp
|
90.81 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-30 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | Herabstufung | Erste Group | Buy → Hold |
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific (BSX) Faces Growth Concerns in Key Medical Device Franchises - Yahoo Finance
Boston Scientific stock extends 7-day rebound as Q2 2026 margins expand - AD HOC NEWS
If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today - benzinga.com
Trivium Point Advisory LLC Invests $1.48 Million in Boston Scientific Corporation $BSX - MarketBeat
S&CO Inc. Buys Shares of 169,791 Boston Scientific Corporation $BSX - MarketBeat
AAFMAA Wealth Management & Trust LLC's Boston Scientific Corp(BSX) Holding History - GuruFocus
Mill Capital Management LLC Invests $9.85 Million in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX), What Is Behind The Latest Investor Attention? - finance.yahoo.com
Is Boston Scientific’s (BSX) Buyback at Odds with Its Lower 2026 Growth Guidance? - finance.yahoo.com
Is Boston Scientific (BSX) Still Undervalued After A 50% Fall? - Yahoo Finance
Brazil CADE reviews Boston Scientific’s acquisition of Penumbra - MLex
Boston Scientific (BSX) Faces Growth Slowdown in Key Businesses - Yahoo Finance
Union Bancaire Privee UBP SA Sells 173,105 Shares of Boston Scientific Corporation $BSX - MarketBeat
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet - Yahoo Finance Australia
Here’s What Hurt Boston Scientific Corporation (BSX) in Q2 - Yahoo Finance
Boston Scientific Corporation $BSX Shares Acquired by Y Intercept Hong Kong Ltd - MarketBeat
Security National Bank Grows Holdings in Boston Scientific Corporation $BSX - MarketBeat
QRG Capital Management Inc. Buys 198,951 Shares of Boston Scientific Corporation $BSX - MarketBeat
NewEdge Advisors LLC Sells 27,583 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by Fisher Funds Management LTD - MarketBeat
Brookstone Capital Management Sells 233,448 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp (BSX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Boston Scientific's CEO Bought $9M of His Own Stock - Quiver Quantitative
Boston Scientific (BSX) SVP Emily Woodworth adds 2,930 shares in 401(k) rebalance - Stock Titan
Boston Scientific (NYSE:BSX) Screens as a Decent Value with Strong Fundamentals - ChartMill
Northside Capital Management LLC Purchases 49,189 Shares of Boston Scientific Corporation $BSX - MarketBeat
MiRus founder builds medtech firm worth billions after quest to save others from fate of his mentorAtlanta Business Chronicle - The Business Journals
Boston Scientific Corporation $BSX Shares Sold by E. Ohman J or Asset Management AB - MarketBeat
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific (BSX) CFO adds 9,908 shares through discretionary 401(k) rebalancing - Stock Titan
Handelsbanken Fonder AB Sells 1,002,628 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp (BSX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Boston Scientific Corporation (NYSE:BSX) Receives Average Recommendation of "Moderate Buy" from Brokerages - marketbeat.com
Boston Scientific: The $5.4 Billion Quarter Tells Me The Sell-Off Is Overdone (NYSE:BSX) - Seeking Alpha
Fidelity Series Blue Chip Growth Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific Stock Is Priced As If WATCHMAN Were The Whole Company - Yahoo Finance
Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026? - The Motley Fool
Boston Scientific Executives Set for 35-Minute Wells Fargo Q&A - Stock Titan
Boston Scientific Corporation $BSX Shares Bought by Gradient Investments LLC - MarketBeat
Boston Scientific Corp (BSX) Insider David Habiger Buys 2,100 Sh - GuruFocus
Boston Scientific Corporation $BSX Shares Purchased by PensionDanmark Pensionsforsikringsaktieselskab - marketbeat.com
Boston Scientific (NYSE:BSX) Director David Habiger Acquires 2,100 Shares - MarketBeat
Boston Scientific (NYSE: BSX) director adds 2,100 shares in open-market buy - Stock Titan
Assenagon Asset Management S.A. Cuts Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Needham cuts Boston Scientific stock price target on WATCHMAN sales - Investing.com
A Look at Boston Scientific Corp (BSX) After 3.3% Gain -- GF Val - GuruFocus
FMR LLC (NYSE: BSX) discloses 46.4M-share Boston Scientific stake in 13G/A - Stock Titan
Michael Mahoney Acquires 186,240 Shares of Boston Scientific (NYSE:BSX) Stock - MarketBeat
Boston Scientific (NYSE: BSX) CEO adds 186,240 shares in open-market buy - Stock Titan
Boston Scientific (NYSE: BSX) director adds 1,182 shares in August stock purchases - stocktitan.net
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):